If AEZS-108 works in endometrial cancer … will it work in prostate cancer too?

Earlier this week the Canadian biotech company Aeterna Zentaris announced results from a Phase II trial of its targeted cytotoxic luteinizing hormone releasing hormone (LHRH) analog, AEZS-108, in advanced endometrial cancer. This may have implications for the potential of AEZS-108 in prostate cancer too. … READ MORE …

More about mice and men … and doxorubicin … and Viagra

According to a thoroughly confusing media release from the Virginia Commonwealth University last week, “the impotence drug Viagra, in combination with doxorubicin, a powerful anti-cancer drug, enhances its anti-tumor efficacy in prostate cancer while alleviating the damage to the heart at the same time.” … READ MORE …